2026 Summer Intern - Biochemical and Cellular Pharmacology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Genentech · 1 day ago

2026 Summer Intern - Biochemical and Cellular Pharmacology

Genentech is a leading biotechnology company specializing in drug discovery and development. They are seeking a summer intern to gain a deeper understanding of drug mechanisms of action and to design and perform various assays related to biochemical and cellular pharmacology.

BiotechnologyLife ScienceManufacturing
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Pursue a deeper understanding of drug mechanism of action
Design & perform quantitative cell–based, biochemical, & biophysical assays
Use bespoke analysis to draw conclusions about molecular behavior that isn’t directly observable

Qualification

Basic bench skillsFluorescence imagingCell cultureCommunication skillsCollaboration skillsInterpersonal skills

Required

Must be pursuing a Bachelor's Degree (enrolled student)
Must be pursuing a PhD (enrolled student)
Required Majors: Cell Biology, Biochemistry, Biophysics, Bioengineering/Biomedical Engineering, and related fields
Basic bench skills

Preferred

Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Experience with fluorescence imaging and cell culture is a plus

Benefits

Paid holiday time off benefits

Company

Genentech

company-logo
Genentech is a biotechnology research company that specializes in genetic testing and personalized medicines.

H1B Sponsorship

Genentech has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (167)
2024 (148)
2023 (150)
2022 (178)
2021 (121)
2020 (158)

Funding

Current Stage
Public Company
Total Funding
unknown
2009-03-26Acquired
1999-07-20IPO
1976-01-01Series Unknown

Leadership Team

leader-logo
Ashley Magargee
Chief Executive Officer
linkedin
leader-logo
Michael Laird
Vice President, Global MSAT Drug Substance Biologics Technology and Commercial Products Support
linkedin
Company data provided by crunchbase